Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-15

Clinical Trial Update: MitraClip NT System Post-marketing Surveillance Study - Japan

View source ↗

Summary

A post-marketing surveillance study of the MitraClip NT System in Japan has completed enrollment and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MitraClip NT System

Snippet

Sponsor: Abbott Medical Devices | Conditions: Mitral Regurgitation, Mitral Valve Regurgitation | Status: COMPLETED | Results posted: 2021-04-15